Acquisitions - Additional Information (Detail) (USD $)
|
12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
Non-compete agreement
|
Jun. 30, 2011
Boston Biochem
|
Apr. 01, 2011
Boston Biochem
Developed technology
|
Apr. 01, 2011
Boston Biochem
Trade names
|
Apr. 01, 2011
Boston Biochem
Non-compete agreement
|
Apr. 01, 2011
Boston Biochem
Customer relationships
|
Jun. 30, 2011
Tocris
|
Apr. 28, 2011
Tocris
Developed technology
|
Apr. 28, 2011
Tocris
Trade names
|
Apr. 28, 2011
Tocris
Customer relationships
|
|
Business Acquisition [Line Items] | ||||||||||
Acquired intangible assets | $ 1,900,000 | $ 1,700,000 | $ 400,000 | $ 300,000 | $ 25,300,000 | $ 16,500,000 | $ 6,600,000 | |||
Acquired intangible assets, useful life (in years) | 5 years | 12 years | 12 years | 5 years | 12 years | 15 years | 10 years | 13 years | ||
Business acquisition, transaction costs | $ 148,000 | $ 1,600,000 |
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The amount of acquisition cost of a business combination allocated to an identifiable intangible asset that will be amortized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|